Free Trial

ESSA Pharma (EPIX) SEC Filings & 10K Form

ESSA Pharma logo
$1.83 +0.07 (+3.98%)
(As of 11/22/2024 ET)

Recent ESSA Pharma SEC Filings

DateFilerForm TypeView
11/14/2024
6:32 PM
BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
Form SC 13G/A
11/14/2024
5:56 AM
ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/08/2024
3:56 PM
ESSA Pharma (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13D
11/07/2024
11:50 AM
BML Investment Partners, L.P. (Filed by)
ESSA Pharma (Subject)
Form SC 13G
11/05/2024
11:06 AM
BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:30 PM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
2:00 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
1:03 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
5:57 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:00 AM
ESSA Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
6:01 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:00 AM
ESSA Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
6:01 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:17 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
9:35 AM
ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
5:16 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
2:02 PM
ESSA Pharma (Subject)
Virsik Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
11:34 AM
ESSA Pharma (Issuer)
Kantoff Philip W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:35 AM
ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:36 AM
ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:38 AM
ESSA Pharma (Issuer)
Requadt Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:39 AM
ESSA Pharma (Issuer)
Sollis Gary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:40 AM
ESSA Pharma (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:41 AM
ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:25 AM
Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:27 AM
ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:30 AM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:31 AM
ESSA Pharma (Issuer)
Wood David S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:32 AM
BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:33 AM
ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:18 PM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
5:50 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:05 AM
ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
02/13/2024
6:01 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
6:01 AM
ESSA Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2024
5:04 AM
BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
Form SC 13G/A
02/08/2024
10:29 AM
ESSA Pharma (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/07/2024
10:29 AM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:27 AM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
8:15 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:09 PM
ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
Form SC 13G/A
New post-election stock warning from Wall Street (Ad)

If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...

Not everything is as rosy as it seems on Wall Street.
01/17/2024
7:57 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
12:41 PM
ESSA Pharma (Issuer)
Requadt Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
2:50 PM
ESSA Pharma (Subject)
Gagnon Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:06 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
8:57 PM
ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:00 AM
ESSA Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/12/2023
6:01 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
10:11 AM
ESSA Pharma (Issuer)
Wood David S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EPIX) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners